[A case of colorectal neuroendocrine carcinoma effectively treated with bevacizumab+levofolinate+5-FU chemotherapy].

Yabuki, Hiroshi; Suto, Takeshi; Inoue, Koetsu; Fujimoto, Hiroto; Sato, Toshihiko; Ikeda, Eiichi; Iizawa, Hajime

Yabuki, Hiroshi; Suto, Takeshi; Inoue, Koetsu; Fujimoto, Hiroto; Sato, Toshihiko; Ikeda, Eiichi; Iizawa, Hajime.

Affiliation

Yabuki H; Dept. of Surgery, Yamagata Prefectural Central Hospital, Japan.

Gan To Kagaku Ryoho ; 39(7): 1139-42, 2012 Jul.

Article in Ja | MEDLINE | ID: mdl-22790056

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Neuroendocrine/drug therapy; Colorectal Neoplasms/drug therapy; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Bevacizumab; Carcinoma, Neuroendocrine/pathology; Carcinoma, Neuroendocrine/surgery; Colorectal Neoplasms/pathology; Colorectal Neoplasms/surgery; Combined Modality Therapy; Female; Fluorouracil/administration & dosage; Humans; Levoleucovorin/administration & dosage; Tomography, X-Ray Computed

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Neuroendocrine Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: Ja Year: 2012 Type: Article

Search on Google

XML

PubMed Links